How a big biotech’s start-up gamble went wrong
Behind the Money
00:00
Icahn's Letter to Alumina's Shareholders
By March of this year, Icahn had amassed a small 1.4% stake in alumina worth some $400 million. His next step? Sit down and write a letter to alumina's shareholders that naturally quoted Shakespeare's play Hamlet. He said the idea of buying grail hasn't gone well. And he made these allegations that Tussuza had actually handpicked all the board members.
Transcript
Play full episode
